From: Direct cell reprogramming for tissue engineering and regenerative medicine
Cell Source | Transdifferentiation Method | Target Cell Type | Reprogramming Factors | References |
---|---|---|---|---|
Human Adult Dermal Fibroblast | Viral Vectors | Neurons | Brn2, Mty1l, miRNA-124 | Ambasudhan et al. (2011) [22] |
Human Adult Peripheral Blood Mononuclear Cells | Electroporation | Â | Ascl1, Brn2, Myt1l, Ngn2 | Tanabe et al. (2018) [27] |
Human Striatum Astrocytes | Viral Vectors | Â | Ascl1, Brn2, Myt1l | Torper et al. (2013) [40] |
Murine Embryonic and Postnatal Fibroblasts | Viral Vectors | Â | Ascl1, Brn2, Myt1l | Vierbuchen et al. (2010) [17] |
Murine Bone Marrow Stromal Cells | Pharmacological Agents | Â | Dimethylsulphoxide, butylated hydroxy-anisole, KCl, valproic acid, forskolin, hydrocortisone, insulin | Zurita et al. (2008) [41] |
Human Neonatal Fibroblasts | Viral Vectors | Hepatocytes | Foxa2, Hnf4α, C/EBPβ, c-Myc | Kogiso et al. (2013) [23] |
Human Embryonic Fibroblasts | Viral Vectors |  | Hnf1α, Hnf4α, Foxa3 | Huang et al. (2014) [24] |
Murine Pancreatic Cells | Pharmacological Agents | Â | Dexamethasone, oncostatin M | Shen et al. (2003) [33] |
Human Adult Fibroblasts | Viral Vectors | Endothelial Cells | ETV2 | Morita et al. (2014) [4] |
Murine Amniotic Cells | Viral Vectors | Â | Sox17 | Schachterle et al. (2017) [26] |
Human Newborn Dermal and Lung Fibroblasts | Viral Vectors Pharmacological Agents |  | Oct4, Sox2, KLF4, c-Myc bFGF, βME | Margariti et al. (2012) [25] |
Human Newborn Foreskin Fibroblasts | Pharmacological Agents | Â | Polyinosinic:polycytidylic acid | Sayed et al. (2015) [12] |
Murine Embryonic Fibroblasts | Pharmacological Agents | Skeletal Myocytes | 5-azacytidine | Kaur et al. (2014) [13] |
Murine Embryonic Fibroblasts | CRISPR/dCas9 | Â | Myod1 | Chakraborty et al. (2014) [8] |
Human Dermal Fibroblasts | Viral Vectors Pharmacological Agents | Â | Myod1 SB431542, Chir99021, EGF, IGF1 | Boularaoui et al. (2018) [58] |
Human Dermal Fibroblasts | Pharmacological Agents | Chondrocytes | Cartilage-derived morphogenetic protein 1 | Yin et al. (2010) [61] |
Mouse Dermal Fibroblast | Viral Vectors | Â | c-Myc, KLF4, Sox9 | Outani et al. (2013) [62] |
Murine Adult Pancreatic Exocrine Cells | Viral Vectors (in situ) | Pancreatic β-Cells | Pdx1, Ngn3, Mafa | Zhou et al. (2008) [64] |
Human Pancreatic Exocrine Cells | Viral Vectors | Â | MAPK, STAT3 | Lemper et al. (2015) [65] |
Murine Cardiac Fibroblasts | Viral Vectors (in situ) | Cardiomyocytes | Gata4, Mef2c, Tbx5 | Qian et al. (2012) [75] |
Murine Bone Marrow Mesenchymal Stem Cells | Pharmacological Agents | Â | 5-azacytidine, Zebularine | Naeem et al. (2013) [14] |
Murine Cardiac Fibroblasts | Pharmacological Agents | Â | miRNA-1, miRNA-133, miRNA-208, miRNA-499 | Jayawardena et al. (2015) [85] |
Murine Myoblasts | CRISPR/Cas9 | Adipocytes | Myod1 | Wang et al. (2017) [28] |
Human Skeletal Muscle Fibroblasts | Pharmacological Agents |  | Dexamethasone, 1-methyl-3-isobutylxanthine, PPARγ agonists | Agley et al. (2013) [34] |
Human Subcutaneous Adipocytes | Pharmacological Agents | Osteoblasts | Calcitriol, dexamethasone, ascorbic acid, and beta-glycerophosphate | Justesen et al. (2004) [35] |
Murine Adipose Tissue-Derived Stem Cells | Viral Vectors | Â | Runx2 | Zhang et al. (2006) [86] |
Murine Preadipocytes | Viral Vectors | Â | Runx2, MKP-1 | Takahashi et al. (2011) [87] |